Business Wire
BusinessIntel says Tesla will use its next-generation 14A foundry process as chip output ramps at 18A nodeThe Apex TimesBusinessVerizon rolls out new customer perks after raising prices, aiming to soften the impact for wireless usersThe Apex TimesBusinessDelta CEO outlines airfares may not fall soon, tying prices to fuel costsThe Apex TimesBusinessBerkshire Hathaway’s post-Buffett question: can its “capital allocation machine” still beat the market?The Apex TimesBusinessNetflix releases trailer for Daniele Luchetti’s ‘You, Me, Us,’ set for Oct. 29 debutThe Apex TimesBusinessNVIDIA’s shares gained less than expected as market attention shifted to its AI supply chainThe Apex TimesBusinessBlackRock Bitcoin ETF sees a $165 million weekly decline, reigniting questions about crypto ETF momentumThe Apex TimesBusinessBroadcom shares lag for a year as some analysts see 50% upsideThe Apex TimesBusinessAmazon stock tests investor patience as pundits question whether it can clear its $220 billion capital-allocation barThe Apex TimesBusinessMeta faces a numbers shake-up as analysts weigh an $18 billion teen-safety plan ahead of earningsThe Apex TimesBusinessAlphabet’s Low Price-to-Earnings Valuation Draws Skepticism, While Investors Still Bet on AIThe Apex TimesBusinessCostco vs. Walmart: Stock performance and “moat” debate refocus on retail economicsThe Apex TimesBusinessIntel says Tesla will use its next-generation 14A foundry process as chip output ramps at 18A nodeThe Apex TimesBusinessVerizon rolls out new customer perks after raising prices, aiming to soften the impact for wireless usersThe Apex TimesBusinessDelta CEO outlines airfares may not fall soon, tying prices to fuel costsThe Apex TimesBusinessBerkshire Hathaway’s post-Buffett question: can its “capital allocation machine” still beat the market?The Apex TimesBusinessNetflix releases trailer for Daniele Luchetti’s ‘You, Me, Us,’ set for Oct. 29 debutThe Apex TimesBusinessNVIDIA’s shares gained less than expected as market attention shifted to its AI supply chainThe Apex TimesBusinessBlackRock Bitcoin ETF sees a $165 million weekly decline, reigniting questions about crypto ETF momentumThe Apex TimesBusinessBroadcom shares lag for a year as some analysts see 50% upsideThe Apex TimesBusinessAmazon stock tests investor patience as pundits question whether it can clear its $220 billion capital-allocation barThe Apex TimesBusinessMeta faces a numbers shake-up as analysts weigh an $18 billion teen-safety plan ahead of earningsThe Apex TimesBusinessAlphabet’s Low Price-to-Earnings Valuation Draws Skepticism, While Investors Still Bet on AIThe Apex TimesBusinessCostco vs. Walmart: Stock performance and “moat” debate refocus on retail economicsThe Apex TimesBusinessIntel says Tesla will use its next-generation 14A foundry process as chip output ramps at 18A nodeThe Apex TimesBusinessVerizon rolls out new customer perks after raising prices, aiming to soften the impact for wireless usersThe Apex TimesBusinessDelta CEO outlines airfares may not fall soon, tying prices to fuel costsThe Apex TimesBusinessBerkshire Hathaway’s post-Buffett question: can its “capital allocation machine” still beat the market?The Apex TimesBusinessNetflix releases trailer for Daniele Luchetti’s ‘You, Me, Us,’ set for Oct. 29 debutThe Apex TimesBusinessNVIDIA’s shares gained less than expected as market attention shifted to its AI supply chainThe Apex TimesBusinessBlackRock Bitcoin ETF sees a $165 million weekly decline, reigniting questions about crypto ETF momentumThe Apex TimesBusinessBroadcom shares lag for a year as some analysts see 50% upsideThe Apex TimesBusinessAmazon stock tests investor patience as pundits question whether it can clear its $220 billion capital-allocation barThe Apex TimesBusinessMeta faces a numbers shake-up as analysts weigh an $18 billion teen-safety plan ahead of earningsThe Apex TimesBusinessAlphabet’s Low Price-to-Earnings Valuation Draws Skepticism, While Investors Still Bet on AIThe Apex TimesBusinessCostco vs. Walmart: Stock performance and “moat” debate refocus on retail economicsThe Apex TimesBusinessIntel says Tesla will use its next-generation 14A foundry process as chip output ramps at 18A nodeThe Apex TimesBusinessVerizon rolls out new customer perks after raising prices, aiming to soften the impact for wireless usersThe Apex TimesBusinessDelta CEO outlines airfares may not fall soon, tying prices to fuel costsThe Apex TimesBusinessBerkshire Hathaway’s post-Buffett question: can its “capital allocation machine” still beat the market?The Apex TimesBusinessNetflix releases trailer for Daniele Luchetti’s ‘You, Me, Us,’ set for Oct. 29 debutThe Apex TimesBusinessNVIDIA’s shares gained less than expected as market attention shifted to its AI supply chainThe Apex TimesBusinessBlackRock Bitcoin ETF sees a $165 million weekly decline, reigniting questions about crypto ETF momentumThe Apex TimesBusinessBroadcom shares lag for a year as some analysts see 50% upsideThe Apex TimesBusinessAmazon stock tests investor patience as pundits question whether it can clear its $220 billion capital-allocation barThe Apex TimesBusinessMeta faces a numbers shake-up as analysts weigh an $18 billion teen-safety plan ahead of earningsThe Apex TimesBusinessAlphabet’s Low Price-to-Earnings Valuation Draws Skepticism, While Investors Still Bet on AIThe Apex TimesBusinessCostco vs. Walmart: Stock performance and “moat” debate refocus on retail economicsThe Apex Times
Back to front
Oracle outlines a renewed push to bring AI into healthcare, tying new deployments to its broader cloud strategy
The Apex Times

THE APEX TIMES

Business/The Apex Times/Aug 19, 3:26 PM EDT

Oracle outlines a renewed push to bring AI into healthcare, tying new deployments to its broader cloud strategy

A new media report says Oracle is expanding its healthcare artificial intelligence efforts, positioning medical use cases as a growing part of its growth narrative even as specifics remain limited.

Oracle is stepping up its focus on healthcare artificial intelligence, according to a new report by Yahoo Finance, which frames healthcare AI as an increasingly important element of the company’s growth story.

The report characterizes the latest move as a “fresh” push into healthcare, suggesting Oracle is looking to translate its enterprise cloud and data capabilities into more concrete deployments in regulated health environments where workflow integration, data quality, and security are central concerns.

Oracle’s pitch in this area, broadly speaking, fits with its long-running strategy of selling software and infrastructure through its cloud platform. In healthcare, that typically means working with patient and operational data, supporting analytics and decision support, and integrating with existing systems used by hospitals, payers, and health IT vendors.

For Oracle, the opportunity is not just software revenue but also the stickiness that comes from embedding AI-enabled capabilities into mission-critical processes. Once AI tools are integrated into clinical or administrative workflows, customers often have incentives to continue using the same underlying platforms to manage data governance, reporting, and ongoing model performance.

However, the report as provided here does not include granular details about which specific healthcare product, customer program, or technology component is being launched. It also does not provide quantified financial impact, such as revenue contribution, bookings, or customer counts.

That means investors and industry observers will likely be looking for additional disclosures from Oracle, such as product documentation, customer references, contract announcements, or commentary in earnings materials that ties healthcare AI initiatives to measurable commercial momentum.

In the broader sector, healthcare AI continues to attract attention because health systems are under pressure to reduce administrative burden and manage complexity in clinical data. At the same time, the market has become crowded with vendors offering varied approaches, from analytics platforms to generative AI for documentation and support.

The key near-term question is whether Oracle’s next healthcare AI step will be tied to a clearly defined offering and delivery timeline, and whether it comes with disclosed outcomes or customer commitments that can be evaluated beyond marketing-level positioning.

Why It Matters

  • Healthcare AI is an important battleground for enterprise cloud providers, because deployments can become embedded in long-term operational workflows.
  • If Oracle can convert healthcare use cases into repeatable offerings, it could strengthen demand for its cloud services and related software.
  • The lack of disclosed specifics makes it difficult to assess commercial traction, so future filings or product updates will matter for understanding whether this is a major step or incremental expansion.
  • Competitive pressure remains high in healthcare AI, making differentiation and measurable outcomes key to sustained momentum.

Sources

Key Facts

  • Yahoo Finance reported that Oracle is making a renewed, “fresh” push to expand artificial intelligence into healthcare.
  • The report frames healthcare AI as a growing part of Oracle’s overall growth narrative.
  • Oracle is positioning healthcare AI as a natural extension of its enterprise cloud and data capabilities, though the provided materials do not specify which exact product is involved.
  • No quantified financial details, customer names, contract values, or deployment timelines are included in the information provided here.

Technology Related

Oct 18, 10:58 AM EDT
The Apex Times

Broadcom shares lag for a year as some analysts see 50% upside

Broadcom Inc. (AVGO) has delivered a sluggish stretch for investors, with the stock down over the past six months even as at least some Wall Street analysts argue the market is undervaluing the company.

Broadcom shares lag for a year as some analysts see 50% upside
The Apex Times